How Should Elderly Candidates for Renal Tranplantation Be Evaluated?
Didier A. Mandelbrot(UW Health University Hospital), Milagros Samaniego(Henry Ford Health System), James R. Rodrigue(Harvard University), Silas P. Norman(University of Michigan), A. Fleishman, Fu L. Luan(Cornell University)
Cited by 0
Related Papers
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy
|American Journal of Transplantation|2004|283
Rapamycin is an effective inhibitor of human renal cancer metastasis11See Editorial by Sukhatme and Strom, p. 1160.
|Kidney International|2003|208
Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant Recipients
|Journal of the American Society of Nephrology|2015|193